Results 181 to 190 of about 1,641,713 (205)
Using tissue‐engineered cartilage from human chondrocytes subjected to mechanical loading in vitro, our study showed for the first time that the sensory neuropeptide aCGRP can impair load‐stimulated proteoglycan production by human chondrocytes, and thus interferes with their anabolic response to physiological mechanical loading.
Helen F. Dietmar +7 more
wiley +1 more source
Serum Concentration Relationships of Candesartan in Migraine Prevention
ABSTRACT Migraine is a common disabling disorder, and optimising affordable preventive treatments remains highly relevant. Candesartan is an effective and well‐tolerated preventive treatment, but little is known about its dose‐concentration–response relationships.
Hedda Skogum Riise +13 more
wiley +1 more source
Background and Purpose The persistence of temporomandibular disorders (TMDs), particularly myogenous, in a person with migraine can lead to exacerbated clinical outcomes and limited response to treatment. The pro‐nociceptive reactive nitroxidative species, peroxynitrite, is involved in migraine mechanisms, but little is known of its role in this ...
Simon Akerman +4 more
wiley +1 more source
ABSTRACT Aims White adipose tissue (WAT) innervation by sensory and sympathetic axons contributes to tissue functions, but the consequences of selectively disrupting sympathetic input to WAT remain incompletely defined. Materials and Methods We utilised 6‐hydroxydopamine (6‐OHDA) as a validated approach to achieve bilateral sympathetic denervation of ...
Gilian Gunsch +15 more
wiley +1 more source
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn +5 more
wiley +1 more source
Molecular Pharmacology of the Calcitonin Receptor
The peptide hormone calcitonin is widely used therapeutically in the treatment of bone disorders such as Paget's disease, osteoporosis, and the hypercalcemia of some malignancies.
Patrick M. Sexton
exaly +2 more sources
The expressions of the calcitonin receptor (CTR), the calcitonin receptor-like receptor (CLR), the receptor activity-modifying proteins (RAMP) 1-3, and of the receptor component protein (RCP) have been studied in mouse bone marrow macrophages (BMM ...
Ulf H Lerner, Pernilla Lundberg
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Critical Care Management of Chimeric Antigen Receptor T-Cell Therapy Recipients
Ca-A Cancer Journal for Clinicians, 2022Sandrine Valadè +2 more
exaly

